Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms
Consumption of dietary natural components such as genistein (GE) found in soy-rich sources is strongly associated with a lower risk of breast cancer. However, bioactive dietary component-based therapeutic strategies are largely understudied in breast cancer treatment. Our investigation sought to elu...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/56c87986f1564d0da6f64f3fa99de391 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:56c87986f1564d0da6f64f3fa99de391 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:56c87986f1564d0da6f64f3fa99de3912021-11-25T18:35:29ZTherapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms10.3390/nu131139442072-6643https://doaj.org/article/56c87986f1564d0da6f64f3fa99de3912021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6643/13/11/3944https://doaj.org/toc/2072-6643Consumption of dietary natural components such as genistein (GE) found in soy-rich sources is strongly associated with a lower risk of breast cancer. However, bioactive dietary component-based therapeutic strategies are largely understudied in breast cancer treatment. Our investigation sought to elucidate the potential mechanisms linking bioactive dietary GE to its breast cancer chemotherapeutic potential in a special subtype of aggressive breast cancer—triple-negative breast cancer (TNBC)—by utilizing two preclinical patient-derived xenograft (PDX) orthotopic mouse models: BCM-3204 and TM00091. Our study revealed that administration of GE resulted in a delay of tumor growth in both PDX models. With transcriptomics analyses in TNBC tumors isolated from BCM-3204 PDXs, we found that dietary soybean GE significantly influenced multiple tumor-regulated gene expressions. Further validation assessment of six candidate differentially expressed genes (DEGs)—<i>Cd74</i>, <i>Lpl</i>, <i>Ifi44</i>, <i>Fzd9</i>, <i>Sat1</i> and <i>Wwc1</i>—demonstrated a similar trend at gene transcriptional and protein levels as observed in RNA-sequencing results. Mechanistically, GE treatment-induced <i>Cd74</i> downregulation regulated the NF-κB/Bcl-xL/TAp63 signal pathway, which may contribute to soybean GE-mediated therapeutic effects on TNBC tumors. Additionally, our findings revealed that GE can modify expression levels of key epigenetic-associated genes such as DNA methyltransferases (<i>Dnmt3b</i>), ten-eleven translocation (<i>Tet3</i>) methylcytosine dioxygenases and histone deacetyltransferase (<i>Hdac2</i>), and their enzymatic activities as well as genomic DNA methylation and histone methylation (H3K9) levels. Collectively, our investigation shows high significance for potential development of a novel therapeutic approach by using bioactive soybean GE for TNBC patients who have few treatment options.Manvi SharmaItika AroraMin ChenHuixin WuMichael R. CrowleyTrygve O. TollefsbolYuanyuan LiMDPI AGarticlegenisteintriple-negative breast cancer (TNBC)patient-derived xenograft (PDX)epigeneticRNA-seqcancer therapyNutrition. Foods and food supplyTX341-641ENNutrients, Vol 13, Iss 3944, p 3944 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
genistein triple-negative breast cancer (TNBC) patient-derived xenograft (PDX) epigenetic RNA-seq cancer therapy Nutrition. Foods and food supply TX341-641 |
spellingShingle |
genistein triple-negative breast cancer (TNBC) patient-derived xenograft (PDX) epigenetic RNA-seq cancer therapy Nutrition. Foods and food supply TX341-641 Manvi Sharma Itika Arora Min Chen Huixin Wu Michael R. Crowley Trygve O. Tollefsbol Yuanyuan Li Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms |
description |
Consumption of dietary natural components such as genistein (GE) found in soy-rich sources is strongly associated with a lower risk of breast cancer. However, bioactive dietary component-based therapeutic strategies are largely understudied in breast cancer treatment. Our investigation sought to elucidate the potential mechanisms linking bioactive dietary GE to its breast cancer chemotherapeutic potential in a special subtype of aggressive breast cancer—triple-negative breast cancer (TNBC)—by utilizing two preclinical patient-derived xenograft (PDX) orthotopic mouse models: BCM-3204 and TM00091. Our study revealed that administration of GE resulted in a delay of tumor growth in both PDX models. With transcriptomics analyses in TNBC tumors isolated from BCM-3204 PDXs, we found that dietary soybean GE significantly influenced multiple tumor-regulated gene expressions. Further validation assessment of six candidate differentially expressed genes (DEGs)—<i>Cd74</i>, <i>Lpl</i>, <i>Ifi44</i>, <i>Fzd9</i>, <i>Sat1</i> and <i>Wwc1</i>—demonstrated a similar trend at gene transcriptional and protein levels as observed in RNA-sequencing results. Mechanistically, GE treatment-induced <i>Cd74</i> downregulation regulated the NF-κB/Bcl-xL/TAp63 signal pathway, which may contribute to soybean GE-mediated therapeutic effects on TNBC tumors. Additionally, our findings revealed that GE can modify expression levels of key epigenetic-associated genes such as DNA methyltransferases (<i>Dnmt3b</i>), ten-eleven translocation (<i>Tet3</i>) methylcytosine dioxygenases and histone deacetyltransferase (<i>Hdac2</i>), and their enzymatic activities as well as genomic DNA methylation and histone methylation (H3K9) levels. Collectively, our investigation shows high significance for potential development of a novel therapeutic approach by using bioactive soybean GE for TNBC patients who have few treatment options. |
format |
article |
author |
Manvi Sharma Itika Arora Min Chen Huixin Wu Michael R. Crowley Trygve O. Tollefsbol Yuanyuan Li |
author_facet |
Manvi Sharma Itika Arora Min Chen Huixin Wu Michael R. Crowley Trygve O. Tollefsbol Yuanyuan Li |
author_sort |
Manvi Sharma |
title |
Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms |
title_short |
Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms |
title_full |
Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms |
title_fullStr |
Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms |
title_full_unstemmed |
Therapeutic Effects of Dietary Soybean Genistein on Triple-Negative Breast Cancer via Regulation of Epigenetic Mechanisms |
title_sort |
therapeutic effects of dietary soybean genistein on triple-negative breast cancer via regulation of epigenetic mechanisms |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/56c87986f1564d0da6f64f3fa99de391 |
work_keys_str_mv |
AT manvisharma therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms AT itikaarora therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms AT minchen therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms AT huixinwu therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms AT michaelrcrowley therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms AT trygveotollefsbol therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms AT yuanyuanli therapeuticeffectsofdietarysoybeangenisteinontriplenegativebreastcancerviaregulationofepigeneticmechanisms |
_version_ |
1718410954267426816 |